Compliance with patient-reported outcome assessment in glioma patients: predictors for drop out
- PMID: 31385978
- PMCID: PMC6655376
- DOI: 10.1093/nop/npx026
Compliance with patient-reported outcome assessment in glioma patients: predictors for drop out
Abstract
Background: Patient-reported outcomes are of high importance in clinical neuro-oncology. However, assessment is still suboptimal. We aimed at exploring factors associated with the probability for a) drop out of study and b) death during follow-up.
Methods: Patients were assessed twice during follow-up visits scheduled within 3 to 5 months of each other by using 3 validated patient-reported outcome measures (t1: first assessment, t2: second assessment). As "death" was seen as a competing risk for drop out, univariate competing risk Cox regression models were applied to explore factors associated with dropping out (age, gender, WHO grade, living situation, recurrent surgery, Karnofsky Performance Status, time since diagnosis, and patient-reported outcomes assessed by Distress Thermometer, EORTC-QLQ-C30, EORTC-QLQ-BN20, and SCNS-SF-34G).
Results: Two hundred forty-six patients were eligible, 173 (70%) participated. Patients declining participation were diagnosed with glioblastomas more often than with other gliomas (56% vs 39%). At t2, 32 (18%) patients dropped out, n = 14 death-related, n = 18 for other reasons. Motor dysfunction (EORTC-QLQ-BN20) was associated with higher risk for non-death-related drop out (HR: 1.02; 95% CI, 1.00-1.03; P = .03). Death-related drop out was associated with age (HR: 1.09; 95% CI, 1.03-1.14; P = .002), Karnofsky Performance Status (HR: 0.92; 95% CI, 0.88-0.96; P < .001), lower physical functioning (EORTC-QLQ-C30; HR: 0.98; 95% CI, 0.96-1.00; P = .04) and lower motor functioning (EORTC-QLQ-BN20; HR: 1.020; 95% CI, 1.00-1.04; P = .02).
Conclusion: Patients with motor dysfunction and poorer clinical condition seem to be more likely to drop out of studies applying patient-reported outcome measures. This should be taken into account when planning studies assessing glioma patients and for interpretation of results of patient-reported outcome assessments in clinical routine.
Keywords: glioma; neuro-oncology; nonparticipation; study drop out; supportive care.
Similar articles
-
Evaluation of health-related quality of life in Lithuanian brain tumor patients using the EORTC brain cancer module.Medicina (Kaunas). 2012;48(11):588-94. Medicina (Kaunas). 2012. PMID: 23455894
-
Does preoperative health-related quality of life predict survival in high-grade glioma patients? - a prospective study.Br J Neurosurg. 2020 Feb;34(1):28-34. doi: 10.1080/02688697.2019.1698011. Epub 2019 Dec 6. Br J Neurosurg. 2020. PMID: 31809598
-
Translation and validation of the Urdu version of the European organization for research and treatment of cancer core quality of life questionnaire (EORTC QLQ-C30) and brain module (QLQ-BN20) in primary brain tumor patients.J Patient Rep Outcomes. 2021 Sep 6;5(1):79. doi: 10.1186/s41687-021-00354-6. J Patient Rep Outcomes. 2021. PMID: 34487251 Free PMC article.
-
Quality of life in patients with primary and metastatic brain cancer as reported in the literature using the EORTC QLQ-BN20 and QLQ-C30.Expert Rev Pharmacoecon Outcomes Res. 2012 Dec;12(6):831-7. doi: 10.1586/erp.12.70. Expert Rev Pharmacoecon Outcomes Res. 2012. PMID: 23252363 Review.
-
The EORTC QLQ-BN20 for assessment of quality of life in patients receiving treatment or prophylaxis for brain metastases: a literature review.Expert Rev Pharmacoecon Outcomes Res. 2011 Dec;11(6):693-700. doi: 10.1586/erp.11.66. Expert Rev Pharmacoecon Outcomes Res. 2011. PMID: 22098285 Review.
Cited by
-
Clinical Outcome Assessment Tools for Evaluating the Management of Gliomas.Cancers (Basel). 2025 May 14;17(10):1659. doi: 10.3390/cancers17101659. Cancers (Basel). 2025. PMID: 40427156 Free PMC article. Review.
-
Head and neck cancer patients with geriatric deficits are more often non-responders and lost from follow-up in quality of life studies.Eur Arch Otorhinolaryngol. 2024 May;281(5):2619-2626. doi: 10.1007/s00405-024-08528-w. Epub 2024 Mar 1. Eur Arch Otorhinolaryngol. 2024. PMID: 38427043 Free PMC article.
-
Characteristics and patient-reported outcomes associated with dropout in severely affected oncological patients: an exploratory study.BMC Med Res Methodol. 2021 Apr 20;21(1):77. doi: 10.1186/s12874-021-01259-0. BMC Med Res Methodol. 2021. PMID: 33879087 Free PMC article.
-
Supportive Care Needs in Glioma Patients and Their Caregivers in Clinical Practice: Results of a Multicenter Cross-Sectional Study.Front Neurol. 2018 Sep 11;9:763. doi: 10.3389/fneur.2018.00763. eCollection 2018. Front Neurol. 2018. PMID: 30254605 Free PMC article.
-
Neurocognitive functioning and health-related quality of life in adult medulloblastoma patients: long-term outcomes of the NOA-07 study.J Neurooncol. 2020 May;148(1):117-130. doi: 10.1007/s11060-020-03502-y. Epub 2020 May 4. J Neurooncol. 2020. PMID: 32367436 Free PMC article.
References
-
- Robin AM, Kalkanis SN, Rock J et al. . Through the patient’s eyes: an emphasis on patient-centered values in operative decision making in the management of malignant glioma. J Neurooncol. 2014;119(3):473–479. - PubMed
-
- Rooney AG, Carson A, Grant R. Depression in cerebral glioma patients: a systematic review of observational studies. J Natl Cancer Inst. 2011;103(1):61–76. - PubMed
-
- Janda M, Steginga S, Dunn J et al. . Unmet supportive care needs and interest in services among patients with a brain tumour and their carers. Patient Educ Couns. 2008;71(2):251–258. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials